Rivaroxaban at least as effective as marcumar in stroke prevention
Aumiller, J.
MMW Fortschritte der Medizin 152(48): 14
2010
ISSN/ISBN: 1438-3276 PMID: 21222327 Document Number: 638835
Document emailed within 1 workday
Related Documents
Fonyakin On Behalf Of The Working Group Of Researchers, A.V. 2016: APPLICATION Rivaroxaban for Secondary Stroke Prevention in Clinical Practice. RESULTS OF RUSSIAN Prospective, Multicenter, Observational Study NEURO-XAR Kardiologiia 56(4): 49-53Lüders, K.; Konold, P.; Otten, G.; Koslowski, L. 1973: Prevention of postoperative thromboembolism. Randomized, prospective study of the comparison of thromboembolism prevention using anticoagulants (Heparin-Marcumar) and dextran 60 (Macrodex) Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 44(12): 563-569
Kirshner, H.S. 1996: Medical revolution: the prevention and treatment of stroke, 1996. Part 2. Medical prevention of stroke and acute stroke therapy Tennessee Medicine: Journal of the Tennessee Medical Association 89(11): 410-412
Lutsep, H.L. 2007: New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 16(6): 263-267
Kirshner, H.S. 1996: Medical revolution: the prevention and treatment of stroke, 1996. Part 1. Stroke prevention and carotid endarterectomy Tennessee Medicine: Journal of the Tennessee Medical Association 89(10): 374-375
Einecke, D. 2013: Stroke prevention in atrial fibrillation: atrial appendage occlusion again proves to be safe and effective MMW Fortschritte der Medizin 155 Spec no 1(1): 24
Stoopler, E.T. 2010: A response to "Dental implications of acute stroke therapy and anticoagulation for stroke prevention" Compendium of Continuing Education in Dentistry 31(5): 322
Laupacis, A.; Singer, D.; Jacobsen, A.; Dunn, M.; Dalen, J.; Albers, G. 1999: Risk factors for stroke and primary prevention of stroke in atrial fibrillation Journal of Thrombosis and Thrombolysis 7(1): 21-26
Stier, C.T.; Adler, L.A.; Levine, S.; Chander, P.N. 1993: Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 11(3): S37-S42
Lin, Y.; Li, Y-Sheng.; Xu, Q.; Shi, G-Wen.; Li, H-Wei.; Geng, J-Li. 2007: The impact of stroke clinic on improving the compliance with the guidelines for secondary prevention of ischemic stroke Zhonghua Nei Ke Za Zhi 46(9): 736-739
Uchiyama, S. 2010: Results of the Cilostazol Stroke Prevention Study II (CSPS II): a randomized controlled trial for the comparison of cilostazol and aspirin in stroke patients Rinsho Shinkeigaku 50(11): 832-834
Demarin, V.; Lovrencić-Huzjan, A.; Serić, V.; Vargek-Solter, V.; Trkanjec, Z.; Vuković, V.; Lupret, V.; Kalousek, M.; Desyo, D.; Kadojić, D.; Lusić, I.; Dikanović, M.; Vitas, M. 2003: Recommendations for management of patients with cerebral stroke. Part Two: Primary and secondary prevention of cerebral stroke Lijecnicki Vjesnik 125(11-12): 322-328
Nikitin, A.S.; Asratian, S.A.; Averin, A.I.; Kamchatnov, P.R. 2013: Effective decompressive craniotomy in a young patient with massive ischemic stroke Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(12 Part 2): 12-16
Sandiford, P.; Selak, V.; Ghafel, M. 2016: Are ethnic inequalities in 30-day ischaemic stroke survival emerging as treatment becomes more effective? New Zealand Medical Journal 129(1437): 8-14
Boone, S. 2015: Cardiac Tamponade Associated with Rivaroxaban Delaware Medical Journal 87(7): 206-207
Wiontzek, H. 1970: Liver diseases induced by Marcumar Deutsche Medizinische Wochenschrift 95(7): 356
Gel'tser, I.V.; Smirnova, O.A.; Matvienko, O.Yu.; Golovina, O.G.; Papayan, L.P. 2015: Change of Anticoagulant Effect of Rivaroxaban During a day Vestnik Khirurgii Imeni I. I. Grekova 174(4): 77-79
Glogner, P.; Heni, N. 1973: Pharmacokinetica and metabolism of phenprocoumon--"marcumar" in man Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 1308-1311
Špinar, J.řich.; Špinarová, L. 2018: Rivaroxaban in high-risk patients Vnitrni Lekarstvi 63(6): 424-430
Algra, A. 1994: SPIRIT: new life spirit for anticoagulant treatment in the secondary prevention of brain infarcts? A new study. Stroke Prevention in Reversible Ischaemia Trial Nederlands Tijdschrift Voor Geneeskunde 138(20): 1037-1039